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Abstract
Few studies have been conducted to determine 
the prevalence of chronic diseases and its impact 
in individuals aged 40 years or over in Brazil. The 
objective of this study is to evaluate the prevalence 
of some common chronic diseases in the Brazilian 
subgroup assessed by the PLATINO study using 
a self-reported survey. A total of 918 individu-
als (55% women) with a mean age of 54.6 ± 10.9 
years were evaluated. The most prevalent diseases 
were obesity (62.5%), hypertension (39.2%) and 
gastritis (30.9%). We conclude from this study 
that there is a high prevalence of chronic diseases 
in the population over 40 years of age: 88% of the 
population suffers from a minimum of one dis-
ease and 26% of the sample suffers from at least 
three diseases. We also observed that the number 
of comorbidities increases with age.
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Introduction
Public health programs are generally designed 
according to the prevalence of the diseases 
they are targeted at. In Brazil, a national survey 
(PNAD – Brazilian National Household Sam-
pling Survey) carried out over the last 42 years 
by the central government has been used as an 
important source of information for developing 
public health service guidelines 1. Other surveys 
that focus on specific groups have also been car-
ried out and provide interesting information that 
has been used by the public health authorities. 
One such study is the EPIDOSO Survey that has 
followed up an ageing population 2 in São Paulo 
over the last two decades evaluating the most 
prevalent diseases in the individuals studied. 
However, this study presents a selection bi-
as since the sample, taken from only two areas 
nearby the University, is not representative of the 
population of São Paulo 2 . As this population was 
not randomized it is possible that the samples 
are strongly subject to chance: the population 
of the study comprised only groups of individu-
als who were already sick or healthy individuals, 
both of which were seeking quality health care. 
With respect to the 2003 PNAD Survey 1, 70% 
of the sample population was under 40 years of 
age, not reflecting the real demographic situa-
tion in Brazil [Brazilian Institute of Geography 
and Statistics (Instituto Brasileiro de Geografia 
e Estatística – IBGE)]. In addition, the survey did 
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not evaluate two very common clinical situations 
in Brazil: chronic obstructive pulmonary disease 
and obesity.
Population based sampling is the ideal meth-
od to evaluate the actual prevalence of a disease 
and assess the level of access a given population 
has to public health care 1,2,3. With respect to dis-
ease prevalence, a strong correlation has already 
been shown between self-diagnosis and diagno-
sis based on clinical evaluation 4.
The Latin American Project for the Investi-
gation of Obstructive Lung Disease (PLATINO) 
aimed to determine the prevalence of chronic 
obstructive pulmonary disease and associated 
risk factors in five major metropolitan areas 
in Latin America: São Paulo (Brazil), Santiago 
(Chile), Mexico City (Mexico), Montevideo 
(Uruguay) and Caracas (Venezuela). The study 
consisted of a randomized household survey 
that used a questionnaire to collect data on the 
prevalence of chronic obstructive pulmonary 
disease, as well as the demographic, spirometry 
and general characteristics of the population. In 
the case of Brazil, the questionnaire  included 
questions about prevalent diseases among the 
sample population 3. In São Paulo, the study 
found a high prevalence of chronic obstructive 
pulmonary disease (15.8%) 3 and  over 60% of the 
sample population was shown to be overweight 
or obese 5. Obesity is strongly associated with 
cardiovascular diseases, diabetes and metabolic 
syndrome, diseases that usually impose a high 
burden on the health care system. 
Despite the methodological quality of the 
EPIDOSO and PNAD studies, neither evaluated 
lung function or individuals’ body mass index by 
measuring the height and weight of individuals 
at their homes. A definitive diagnosis of chronic 
obstructive pulmonary disease can only be made 
using spirometry. 
Other diseases with high morbidity and mor-
tality that impose a high burden on the health 
care system were also evaluated by the PLATINO 
study. Information regarding prevalence of asth-
ma, tuberculosis, heart disease, systemic arte-
rial hypertension, diabetes, lung cancer, stroke, 
gastritis and ulcers were collected using a self-
reported method. 
This study consists of a subanalysis of the 
PLATINO study and aimed to evaluate the self-
reported prevalence of certain highly prevalent 
chronic diseases in Brazil combining the objec-
tive measurement of lung function, weight and 
height in a cluster analysis of a survey sample in 
the city of São Paulo.
Material and methods
Study design
The study was approved by the Ethics and Re-
search Committee of the São Paulo Federal 
University (Universidade Federal de São Paulo – 
UNIFESP), Brazil, and was based on data collected 
by the PLATINO study. The methods and results 
regarding chronic obstructive pulmonary disease 
prevalence in Latin America have been published 
in previous studies 3,5. Briefly, PLATINO was a 
transversal study designed to determine chronic 
obstructive pulmonary disease prevalence and 
associated risk factors in five large metropolitan 
areas of Latin America, including São Paulo in 
Brazil. The study sample was selected using clus-
ters in several stages. Firstly, the metropolitan ar-
ea was stratified into main city and surrounding 
municipalities. These two subsets were then fur-
ther stratified by socioeconomic status. Based on 
these stratifications we selected 68 census tracts 
using a probability of selection proportionate to 
the number of households in each tract. Within 
each tract, we counted the number of individuals 
in each household and every count was updated 
based on the most recent census. We chose an 
average of 15 households using systematic sam-
pling within each tract. All adults aged 40 years 
or over living in selected households were invited 
to participate and those who accepted signed a 
consent form and were submitted to the evalua-
tions in their home.
Questionnaire and evaluations
All interviews and examinations took place in 
the subject’s home, and proxy information was 
not accepted. We obtained data regarding re-
spiratory health using a standardized question-
naire which included sections from the Ameri-
can Thoracic Society Division of Lung Diseases 
(ATS/DLD) 6, European Community Respiratory 
Health Survey II 7 and Lung Health Study instru-
ments 8. This questionnaire has been used to 
investigate respiratory diseases and symptoms 
3,9 in a number of countries, including  Brazil 5. 
Questions related to the presence of respiratory 
symptoms, self-diagnosis of other chronic dis-
eases, such as asthma, heart disease, systemic 
arterial hypertension, diabetes, lung cancer, 
stroke and gastritis or ulcers. The following ques-
tion was asked: “Has a doctor ever told you that 
you have heart disease?”. The same question was 
asked regarding “high blood pressure” (“hiper-
tensão”), “blood sugar” or “diabetes”, “lung can-
cer”, “stroke” or “cerebral ischemia” (“derrame”), 
“lung tuberculosis”, “asthma”, “gastritis or ulcer”. 
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The questionnaire also assessed the number 
of completed school years of each subject and 
smoking history. Height was measured with a 
portable stadiometer (Seca, Curitiba, Brazil; pre-
cision 0.1cm) and subjects were weighed with an 
electronic scale (Tanita; Curitiba, Brazil; preci-
sion 200g) to calculate  their body mass index 
(BMI)  Individuals with a BMI of over 25kg/m2 
were defined as overweight and those with a BMI 
of over 30kg/m2 were considered obese 10. In ad-
dition, pre and post-bronchodilator spirometry 
was performed (Easy-One; NDD Medical Tech-
nologies, Chelmsford, USA, and Zurich, Switzer-
land) and chronic obstructive pulmonary disease 
was diagnosed where the post-bronchodilator 
FEV1/FVC was less than 0.7 11,12,13. If subjects 
answered “yes” to any of the questions related 
to history of previous disease and/or presented 
a BMI of over 25kg/m2 and/or a FEV1/FVC ratio 
lower than 0.70 (chronic obstructive pulmonary 
disease), the data was evaluated to determine 
the prevalence of each disease. In addition, the 
number of diseases presented by each subject 
was verified and stratified/classified as 1-2, 3-4 
or over 5 diseases.
The sample size of this study was determined 
based on the prevalence of chronic obstructive 
pulmonary disease. Sample size calculations 
suggested that 800 individuals would be needed 
to estimate a prevalence of chronic obstructive 
pulmonary disease of up to 30% with a margin 
of error of less than 4 percent. We aimed to locate 
about 1,020 eligible participants per site, with 
a predicted 20% refusal rate. The initial sample 
looked at chronic obstructive pulmonary disease 
prevalence. Only 12% of this sample was defined 
as “not having a self-reported disease”. Based on 
these results and assuming a total amplitude 
confidence interval of 0.10 and a confidence in-
terval of 99%, it was calculated that it would be 
necessary to evaluate a total of 339 subjects 14.
Statistical analysis
Continuous variables are presented as mean ± 
standard deviation. The categorical variables are 
expressed as number of subjects and percentage. 
The chi-square test was used to test the associa-
tion between qualitative variables. The Student’s 
t-test was used to compare the mean of two 
groups. Statistical analysis was performed utiliz-
ing Stata 8.0 (Stata Corp., College Station, USA) 
and SPSS 10.0 (SPSS Inc., Chicago, USA).
The prevalence of each disease or combi-
nation of diseases was calculated for the whole 
sample. In addition, to evaluate and compare the 
prevalence and number of concomitant diseases, 
age was stratified into various groups: 40 to 49 
years, 50 to 59 years, 60 to 69 years and over 70 
years.
The type I error rate was maintained at 5%.
Results
A total of 1,000 subjects completed the question-
naire and 918 performed pre and post-broncho-
dilator spirometry test. The level of non-response 
was 15.3%, including failure to locate the resi-
dence or individual and refusal to take the spiro-
metric test. The age and smoking history charac-
teristics of non-responders and responders were 
similar.
The demographic data is shown in Table 1. 
The age of the sample population ranged pre-
dominantly between 40 and 60 years (72.7%) 
with a mean of 54.6 ± 10.9 years. The sample was 
predominantly female and white. The subjects 
had completed an average of six years of school-
ing. The sample comprised predominantly non-
smokers (42.2%), 32.9% ex-smokers and 24.9% 
current smokers. The mean smoking load was 18 
packs per year.
The prevalence of the diseases studied is 
shown in Figure 1. The number of diseases tend-
Table 1
Demographic and clinical characteristics of the study 
population (n = 918).
Variable Value
Age (years ±) 54.6 (10.9)
Age stratified (years) [n (%)] 
40-49 372 (40.5)
50-59 296 (32.2)
60-69 151 (16.9)
70 and older 99 (10.8)
Gender [n (%)]
Male 413 (45)
Female 505 (55)
Race [n (%)]
White 528 (57.5)
Non white 390 (42.5)
Education (years ±) 6.0 (4.8)
BMI [kg/m2 ± SD] 27.3 (5.5)
Smoking History [pack-years ±] 18.0 (22.8)
Smoking status [n (%)]
Non smoker 387 (42.2)
Ex-smoker 302 (32.9)
Smoker 229 (24.9)
BMI: body mass index; SD: standard deviation.
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ed to increase with age. The most common co-
morbidity was obesity, followed by systemic arte-
rial hypertension. The prevalence of obesity was 
high in all age groups. We also found a low inci-
dence of lung cancer and stroke for all age groups 
(Figure 1).
Comorbidity was associated with age (see Ta-
ble 2). The number of diseases in the population 
increased with age, from 1.6 diseases per person 
in the 40 to 49 years age group to 2.3 diseases per 
person in the 70 years and over age group (see 
Table 2; p < 0.001).
Discussion
This study is a subanalysis of the PLATINO study, 
which was designed to evaluate the prevalence of 
chronic obstructive pulmonary disease in Latin 
America. In our study, the data analysis is re-
stricted to the adult population of São Paulo aged 
40 years and over, a commonly used sample type 
in epidemiological studies regarding chronic ob-
structive pulmonary disease.
Our subanalysis concerned the prevalence of 
ten diseases in the metropolitan area of São Paulo 
using a self-reported questionnaire and objective 
measurements of lung function and BMI 3. The 
Figure 1
Prevalence of diseases by age group.
COPD: chronic obstructive pulmonary disease; SAH: systemic arterial hypertension.
* p < 0.05. Chi-square test.
questionnaire was adapted from standardized 
and validated questionnaires 6,7 which are widely 
used in other respiratory epidemiological studies 
in Europe and Asia 9.
Other surveys undertaken in Brazil and other 
countries have evaluated large samples focusing 
on specific diseases 15,16,17. However, few stud-
ies have analyzed the characteristics of the sur-
veyed individuals associated with these diseases. 
Knowledge of factors associated with these dis-
eases would help to develop a multidimensional 
approach which could be more cost effective for 
the health care system.
Ramos et al. 2 conducted a prevalence study 
of an ageing population, including individuals 
over 65 years of age, in a district of the city of São 
Paulo and found that only 5.6% of the sample did 
not present any chronic disease and reported a 
strong association between diseases. However 
their study was not randomized, was restricted 
to one district of São Paulo and only comprised 
older individuals. Despite these flaws, the very 
low percentage of individuals without any chron-
ic disease is very similar to the findings in our 
subset group aged 60 years and over (6.8%).
An important finding was made regarding 
the number of diseases per individual and age: 
at least 88% of the present study population had 
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Table 2
Number of diseases by age group.
Number 
of chronic 
diseases *
40-49 years 50-59 years 60-69 years Over 70 years
n (%) 95%CI n (%) 95%CI n (%) 95%CI n (%) 95%CI
None 63 (16.9) 13.1-20.7 30 (10.2) 6.8-13.6 11 (7.3) 3.2-11.4 6 (6.1) 1.4-10.8
1-2 237 (63.7) 58.8-68.6 184 (62.4) 56.9-67.9 70 (46.4) 38.4-54.4 58 (58.6) 48.9-68.3
3-4 68 (18.3) 14.4-22.2 72 (24.4) 19.5-29.3 62 (41.1) 33.3-48.9 28 (28.3) 19.4-37.2
> 5 4 (1.1) 0.0-2.2 9 (3.1) 1.1-5.1 8 (5.3) 1.7-8.9 7 (7.1) 2.0-12.2
95%CI: 95% confi dence interval.
* p < 0.001. Chi-square test.
one or two diseases, 60% of the individuals, irre-
spective of the age group, had one or two diseases 
and the percentage of individuals with three or 
more diseases tended to increase with age (Table 
2). Concomitant diseases require comprehensive 
treatment with a multidisciplinary approach and 
can result in potential medication interactions.
We found a high prevalence of individuals 
who were overweight and obese (BMI ≥ 25kg/
m2). Monteiro et al. 18 found a 39% prevalence 
of overweight and obese individuals among 
the Brazilian population, which is a significant 
contrast to the findings of this study (62%). This 
difference may be due to the age group of the 
PLATINO study which included only individu-
als aged 40 years or over, known to have lower 
metabolic activity and a greater tendency to gain 
weight. Recent surveys in Brazil have shown that 
the population tends to be overweight 19. Based 
on data from the NHANES III study in 1999, the 
prevalence of excess weight and obesity in in-
dividuals in the United States aged 25 years or 
over was 63% for men and 55% for women (BMI ≥ 
25kg/m2) 3 , which is similar to the findings of this 
study. Barros et al. 20 studied the social disparities 
related to the prevalence of chronic diseases in 
Brazil and found lower prevalence for individu-
als of the same age group covered by our study. 
Obesity is an important contributor to the devel-
opment of other comorbidities such as diabetes, 
systemic arterial hypertension and cardiovascu-
lar diseases. Combating this problem in health 
programs requires a multifaceted approach in-
cluding knowledge regarding nutrition, exercise 
and metabolism 20.
Population surveys carried out in Brazilian 
cities over the past 20 years have shown a preva-
lence of over 30% of systemic arterial hyperten-
sion in the Brazilian population 21,22, which is 
similar to the findings of this study: 32.3% for the 
40 to 49 years age group and 36.1% for the 50 to 
59 years age group. Findings regarding disease 
prevalence in individuals in the city of São Paulo 
relating to the period 2001 to 2002 published by 
Coutinho et al. 23  were comparable to our study 
for the 40 to 49 years age group (36%) but higher 
in the case of the 50 to 59 years age group (53%). 
The other age groups evaluated by the present 
study were not examined by Coutinho et al. 23. 
These figures are particularly important consid-
ering that this population is more prone to cere-
brovascular accidents and developing ischemic 
cardiovascular diseases and peripheral arterial 
insufficiency 24.
Gastritis and ulcers were ranked as the third 
most common disorder in our sample. However 
it should be noted that self-diagnosis of these dis-
eases is difficult because  their symptoms may be 
confused with other dyspeptic symptoms 25,26. 
We are not aware of any Brazilian data related 
to the prevalence of gastritis or ulcers. In 2002, 
based on a study of gastric biopsies, Coelho at 
al. 27 showed that the estimated prevalence of in-
fection by H. pylori in Latin America was 60%, 
with a wide range of variation from 30% to 90%. 
The prevalence rates found by the present study 
for gastritis (28%) and ulcers (36%) were be-
low the mean value reported by Coelho at al. 27 
but within the range cited by these authors. In 
Brazil, a population-based study 28 indicated a 
prevalence rate of 44% for dyspeptic syndrome. 
Although this syndrome was highly prevalent in 
the general population, only 25% of individuals 
seek medical treatment for this illness. It is there-
fore possible that the number of individuals who 
reported gastritis or ulcers in our study could be 
an underestimate. 
Self-reported heart disease in our study ranks 
fourth in the list of disease prevalence and shows 
an increasing trend with age, reaching 21.2% in 
the 70 years and over age group. The term heart 
disease can encompass various illnesses such as 
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arrhythmia, myocardiopathy, aortic valve dis-
ease and coronary disease (angina). However, 
the questionnaire used in this study was not 
designed to carry out an individual evaluation 
of such diseases. As heart disease is the leading 
cause of mortality in Brazil, this was already an 
expected finding in our study.
The incidence of chronic obstructive pulmo-
nary disease increased with age. The prevalence 
of this disease in São Paulo, which may affect 
as many as seven million people in Brazil, was 
15.8% in individuals aged 40 years and over 3,5. 
It is well known that chronic obstructive pul-
monary disease imposes a substantial burden 
on the Brazilian Unified National Health Sys-
tem (SUS): approximately 180,000 patients per 
year are admitted to hospital due to this disease 
and it was the sixth greatest cause of death in 
Brazil in 2004, with 33,000 deaths (Health In-
formation Department. http://www.datasus.
gov.br, accessed on 12/Oct/2011). Despite the 
high burden on public health, chronic obstruc-
tive pulmonary disease is under diagnosed and 
undertreated 29.
According to the Brazilian Survey on Diabetes 
(1992) carried out by Franco et al. 30, this disease 
was shown to have an age-adjusted prevalence 
(30 to 69 years) of 7.6%, with a variation of 5% 
to 10%, in the different state capitals evaluated 
(6.7%). However,  rates in the present study were 
as high as 17.2% in the 70 years or over age group. 
The increase in prevalence of diabetes in the two 
age groups – 60 to 69 years and 70 years or over – 
may be associated with several factors, including 
the fact that as a person ages the number of in-
sulin receptors decreases and the blood glucose 
levels rise 31.
An important observation of our study is 
that the mean number of diseases per person 
increased with age. This increasing trend in the 
association between chronic comorbidities may 
be due to the chronic character of these diseases, 
associated with the fact that, despite being treat-
able, they are not curable.
One possible limitation of this study is that 
the prevalence of diseases was based on the 
PLATINO questionnaire that concerns only cer-
tain specific diseases. However, it is important to 
highlight that, although the primary objective of 
the PLATINO study was not the same as that of 
the present analysis, the rigorous study design 
and very good quality control acts as an assur-
ance of reliable data. Several other studies have 
also used surveys or questionnaires to identify 
the prevalence of diseases and show health care 
utilization 32,33. It is also important to note that 
the information obtained from the PLATINO 
study has not been previously revealed.
We can make the following conclusions from 
this study: there is a high prevalence of chron-
ic diseases in the Brazilian population aged 40 
years or over; 88% of the population suffers from 
at least one disease and 26% of the individuals of 
our sample had at least three diseases. We also 
observed that the number of comorbidities in-
creases with age.
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Resumo
Poucos estudos foram desenvolvidos para determinar 
a prevalência de doenças crônicas e suas associações 
em indivíduos com mais de 40 anos de idade no Bra-
sil. O objetivo deste trabalho foi avaliar a prevalência 
de algumas doenças crônicas altamente prevalentes 
no país, de modo autorreferido, avaliadas no Estu-
do PLATINO em São Paulo, em uma amostra de base 
populacional. Novecentos e dezoito indivíduos (55% 
mulheres) com média de idade de 54,6 ± 10,9 anos 
foram avaliados. As três doenças mais prevalentes fo-
ram obesidade (62,5%), hipertensão (39,2%) e gastrite 
(30,9%). Há uma alta prevalência de doenças crônicas 
na população acima de 40 anos: 88% da amostra apre-
sentaram pelo menos uma doença e 26%, pelo menos, 
três doenças; e o número de doenças apresentava ten-
dência a aumentar com a idade.
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